companydata.dkcompanydata.dk

PHARMAVEST ApS: Financial statements 2018

CVR: 26385180

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,085,349 and a net result of DKK 360,195 compared with DKK -260,711 the year before. That is an increase of 220.9% compared with the year before. Equity in the 2018 report amounted to DKK 2,944,740. The solvency ratio was 78.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,085,349
Profit/Loss
DKK 360,195
Equity
DKK 2,944,740
Total Assets
DKK 3,732,744
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-1.1 mio.360 t.2.9 mio.1
2017-338 t.-261 t.2.6 mio.1
2016-479 t.-94 t.2.8 mio.1
2015-822 t.57 t.2.9 mio.-
2014-926 t.200 t.2.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

PHARMAVEST ApS: The 2017 annual report is outMay 29, 2018

PHARMAVEST ApS has published its annual report for 2017. Gross profit came to DKK 338,180, and the net result was DKK -260,711.

About PHARMAVEST ApS

PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.

Source: annual report 2025, Danish Business Authority